nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CYP1A2—Anagrelide—hematologic cancer	0.0558	0.0687	CbGbCtD
Promazine—CYP2C9—Bexarotene—hematologic cancer	0.0348	0.0429	CbGbCtD
Promazine—CYP1A2—Carmustine—hematologic cancer	0.0293	0.0361	CbGbCtD
Promazine—CYP2C9—Idarubicin—hematologic cancer	0.0289	0.0356	CbGbCtD
Promazine—CYP2C19—Bortezomib—hematologic cancer	0.0257	0.0316	CbGbCtD
Promazine—CYP1A2—Methoxsalen—hematologic cancer	0.0249	0.0307	CbGbCtD
Promazine—CYP1A2—Bortezomib—hematologic cancer	0.0237	0.0292	CbGbCtD
Promazine—CYP1A2—Daunorubicin—hematologic cancer	0.0227	0.0279	CbGbCtD
Promazine—CYP2C19—Thalidomide—hematologic cancer	0.0224	0.0276	CbGbCtD
Promazine—CYP1A2—Alitretinoin—hematologic cancer	0.0222	0.0274	CbGbCtD
Promazine—CYP2C9—Bortezomib—hematologic cancer	0.0213	0.0263	CbGbCtD
Promazine—CYP2C19—Teniposide—hematologic cancer	0.0213	0.0263	CbGbCtD
Promazine—CYP1A2—Thalidomide—hematologic cancer	0.0206	0.0254	CbGbCtD
Promazine—CYP3A4—Bexarotene—hematologic cancer	0.0202	0.025	CbGbCtD
Promazine—CYP2C19—Ifosfamide—hematologic cancer	0.0197	0.0243	CbGbCtD
Promazine—CYP3A4—Busulfan—hematologic cancer	0.0188	0.0232	CbGbCtD
Promazine—CYP3A4—Lomustine—hematologic cancer	0.0188	0.0232	CbGbCtD
Promazine—CYP2C19—Imatinib—hematologic cancer	0.0188	0.0232	CbGbCtD
Promazine—CYP2C9—Thalidomide—hematologic cancer	0.0186	0.0229	CbGbCtD
Promazine—CYP1A2—Dacarbazine—hematologic cancer	0.0177	0.0219	CbGbCtD
Promazine—CYP2C9—Teniposide—hematologic cancer	0.0177	0.0219	CbGbCtD
Promazine—CYP1A2—Imatinib—hematologic cancer	0.0174	0.0214	CbGbCtD
Promazine—CYP3A4—Thiotepa—hematologic cancer	0.0168	0.0207	CbGbCtD
Promazine—CYP2C9—Ifosfamide—hematologic cancer	0.0164	0.0202	CbGbCtD
Promazine—CYP2C9—Imatinib—hematologic cancer	0.0156	0.0193	CbGbCtD
Promazine—CYP2C9—Nilotinib—hematologic cancer	0.0142	0.0175	CbGbCtD
Promazine—CYP1A2—Dasatinib—hematologic cancer	0.0139	0.0172	CbGbCtD
Promazine—CYP3A4—Methoxsalen—hematologic cancer	0.013	0.0161	CbGbCtD
Promazine—CYP3A4—Bortezomib—hematologic cancer	0.0124	0.0153	CbGbCtD
Promazine—CYP2C19—Prednisone—hematologic cancer	0.0124	0.0153	CbGbCtD
Promazine—CYP3A4—Daunorubicin—hematologic cancer	0.0119	0.0146	CbGbCtD
Promazine—CYP3A4—Cytarabine—hematologic cancer	0.0105	0.0129	CbGbCtD
Promazine—CYP3A4—Teniposide—hematologic cancer	0.0103	0.0127	CbGbCtD
Promazine—CYP3A4—Ifosfamide—hematologic cancer	0.00952	0.0117	CbGbCtD
Promazine—CYP3A4—Imatinib—hematologic cancer	0.00909	0.0112	CbGbCtD
Promazine—CYP1A2—Etoposide—hematologic cancer	0.00868	0.0107	CbGbCtD
Promazine—CYP3A4—Ruxolitinib—hematologic cancer	0.00856	0.0106	CbGbCtD
Promazine—CYP3A4—Nilotinib—hematologic cancer	0.00826	0.0102	CbGbCtD
Promazine—CYP3A4—Vinorelbine—hematologic cancer	0.00819	0.0101	CbGbCtD
Promazine—CYP2C9—Cisplatin—hematologic cancer	0.00796	0.00982	CbGbCtD
Promazine—CYP2C19—Dexamethasone—hematologic cancer	0.00774	0.00954	CbGbCtD
Promazine—CYP3A4—Triamcinolone—hematologic cancer	0.00749	0.00924	CbGbCtD
Promazine—CYP3A4—Dasatinib—hematologic cancer	0.0073	0.009	CbGbCtD
Promazine—CYP3A4—Mitoxantrone—hematologic cancer	0.00721	0.00889	CbGbCtD
Promazine—CYP2C9—Dexamethasone—hematologic cancer	0.00643	0.00793	CbGbCtD
Promazine—CYP3A4—Betamethasone—hematologic cancer	0.00643	0.00793	CbGbCtD
Promazine—CYP3A4—Prednisolone—hematologic cancer	0.00634	0.00782	CbGbCtD
Promazine—CYP3A4—Prednisone—hematologic cancer	0.00599	0.00739	CbGbCtD
Promazine—CYP3A4—Irinotecan—hematologic cancer	0.00568	0.007	CbGbCtD
Promazine—CYP3A4—Vinblastine—hematologic cancer	0.00505	0.00623	CbGbCtD
Promazine—CYP3A4—Vincristine—hematologic cancer	0.00496	0.00612	CbGbCtD
Promazine—CYP3A4—Etoposide—hematologic cancer	0.00455	0.00561	CbGbCtD
Promazine—CYP3A4—Dexamethasone—hematologic cancer	0.00374	0.00461	CbGbCtD
Promazine—CYP3A4—Doxorubicin—hematologic cancer	0.0031	0.00383	CbGbCtD
Promazine—Quetiapine—H1F0—hematologic cancer	0.000535	0.12	CrCbGaD
Promazine—DRD4—testis—hematologic cancer	0.000449	0.0888	CbGeAlD
Promazine—CHRM4—testis—hematologic cancer	0.00034	0.0671	CbGeAlD
Promazine—Chlorphenamine—SLC22A1—hematologic cancer	0.000299	0.067	CrCbGaD
Promazine—Acepromazine—SLC22A1—hematologic cancer	0.000295	0.0662	CrCbGaD
Promazine—Thioproperazine—SLC22A1—hematologic cancer	0.000289	0.0647	CrCbGaD
Promazine—Pipotiazine—SLC22A1—hematologic cancer	0.000284	0.0637	CrCbGaD
Promazine—CYP2C19—hematopoietic system—hematologic cancer	0.000252	0.0498	CbGeAlD
Promazine—ADRA1A—hematopoietic system—hematologic cancer	0.000249	0.0492	CbGeAlD
Promazine—Clomipramine—GSTP1—hematologic cancer	0.000243	0.0544	CrCbGaD
Promazine—CYP1A2—hematopoietic system—hematologic cancer	0.000206	0.0407	CbGeAlD
Promazine—Diphenhydramine—SLC22A1—hematologic cancer	0.000203	0.0455	CrCbGaD
Promazine—CYP2C9—hematopoietic system—hematologic cancer	0.000195	0.0386	CbGeAlD
Promazine—HRH1—hematopoietic system—hematologic cancer	0.000193	0.0381	CbGeAlD
Promazine—ADRA2A—hematopoietic system—hematologic cancer	0.000189	0.0374	CbGeAlD
Promazine—Desipramine—SLC22A1—hematologic cancer	0.000181	0.0405	CrCbGaD
Promazine—CHRM1—lung—hematologic cancer	0.000176	0.0348	CbGeAlD
Promazine—CYP2C19—blood—hematologic cancer	0.000167	0.033	CbGeAlD
Promazine—ADRA1A—blood—hematologic cancer	0.000165	0.0326	CbGeAlD
Promazine—HTR2A—hematopoietic system—hematologic cancer	0.000161	0.0318	CbGeAlD
Promazine—Chlorpromazine—SLC22A1—hematologic cancer	0.000154	0.0345	CrCbGaD
Promazine—Imipramine—SLC22A1—hematologic cancer	0.000153	0.0343	CrCbGaD
Promazine—CYP3A4—hematopoietic system—hematologic cancer	0.000149	0.0294	CbGeAlD
Promazine—CHRM3—testis—hematologic cancer	0.000148	0.0293	CbGeAlD
Promazine—ADRA2A—gonad—hematologic cancer	0.000144	0.0284	CbGeAlD
Promazine—DRD2—lung—hematologic cancer	0.000142	0.028	CbGeAlD
Promazine—Tamoxifen—ABCG2—hematologic cancer	0.000138	0.0309	CrCbGaD
Promazine—CYP1A2—blood—hematologic cancer	0.000136	0.0269	CbGeAlD
Promazine—Tamoxifen—ESR1—hematologic cancer	0.000135	0.0303	CrCbGaD
Promazine—DRD2—testis—hematologic cancer	0.000134	0.0264	CbGeAlD
Promazine—CYP2C9—blood—hematologic cancer	0.000129	0.0256	CbGeAlD
Promazine—ADRA2A—blood—hematologic cancer	0.000125	0.0248	CbGeAlD
Promazine—HTR2A—gonad—hematologic cancer	0.000122	0.0242	CbGeAlD
Promazine—CYP1A2—lung—hematologic cancer	0.000119	0.0236	CbGeAlD
Promazine—Oxcarbazepine—ALB—hematologic cancer	0.000119	0.0267	CrCbGaD
Promazine—HRH1—lung—hematologic cancer	0.000112	0.0221	CbGeAlD
Promazine—ADRA2A—lung—hematologic cancer	0.00011	0.0217	CbGeAlD
Promazine—HTR2A—blood—hematologic cancer	0.000107	0.0211	CbGeAlD
Promazine—HRH1—testis—hematologic cancer	0.000105	0.0209	CbGeAlD
Promazine—Diltiazem—ABCB1—hematologic cancer	0.000104	0.0233	CrCbGaD
Promazine—ADRA2A—testis—hematologic cancer	0.000104	0.0205	CbGeAlD
Promazine—CYP3A4—blood—hematologic cancer	9.86e-05	0.0195	CbGeAlD
Promazine—HTR2A—lung—hematologic cancer	9.34e-05	0.0185	CbGeAlD
Promazine—Triflupromazine—ABCB1—hematologic cancer	9.28e-05	0.0208	CrCbGaD
Promazine—Acepromazine—ALB—hematologic cancer	9e-05	0.0202	CrCbGaD
Promazine—HTR2A—testis—hematologic cancer	8.81e-05	0.0174	CbGeAlD
Promazine—Thioproperazine—ALB—hematologic cancer	8.79e-05	0.0197	CrCbGaD
Promazine—Pipotiazine—ALB—hematologic cancer	8.65e-05	0.0194	CrCbGaD
Promazine—Carbamazepine—ABCB1—hematologic cancer	7.74e-05	0.0174	CrCbGaD
Promazine—HRH1—lymph node—hematologic cancer	7.65e-05	0.0151	CbGeAlD
Promazine—ADRA2A—lymph node—hematologic cancer	7.51e-05	0.0148	CbGeAlD
Promazine—Fluphenazine—ABCB1—hematologic cancer	7.13e-05	0.016	CrCbGaD
Promazine—Clomipramine—ALB—hematologic cancer	6.84e-05	0.0153	CrCbGaD
Promazine—Clomipramine—ABCB1—hematologic cancer	6.53e-05	0.0146	CrCbGaD
Promazine—Chlorprothixene—ABCB1—hematologic cancer	6.5e-05	0.0146	CrCbGaD
Promazine—Trimipramine—ABCB1—hematologic cancer	6e-05	0.0135	CrCbGaD
Promazine—Promethazine—ABCB1—hematologic cancer	5.78e-05	0.013	CrCbGaD
Promazine—Tamoxifen—ABCB1—hematologic cancer	5.74e-05	0.0129	CrCbGaD
Promazine—Doxepin—ABCB1—hematologic cancer	5.72e-05	0.0128	CrCbGaD
Promazine—Trifluoperazine—ABCB1—hematologic cancer	5.7e-05	0.0128	CrCbGaD
Promazine—Quetiapine—ABCB1—hematologic cancer	5.53e-05	0.0124	CrCbGaD
Promazine—Desipramine—ABCB1—hematologic cancer	5.25e-05	0.0118	CrCbGaD
Promazine—Chlorpromazine—ALB—hematologic cancer	4.69e-05	0.0105	CrCbGaD
Promazine—Amitriptyline—ALB—hematologic cancer	4.64e-05	0.0104	CrCbGaD
Promazine—Chlorpromazine—ABCB1—hematologic cancer	4.48e-05	0.01	CrCbGaD
Promazine—Imipramine—ABCB1—hematologic cancer	4.45e-05	0.00998	CrCbGaD
Promazine—Amitriptyline—ABCB1—hematologic cancer	4.42e-05	0.00992	CrCbGaD
Promazine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.53e-06	1.97e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—JUN—hematologic cancer	3.53e-06	1.97e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.52e-06	1.96e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	3.52e-06	1.96e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—TP53—hematologic cancer	3.51e-06	1.96e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	3.51e-06	1.96e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	3.5e-06	1.95e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	3.5e-06	1.95e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PTEN—hematologic cancer	3.5e-06	1.95e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—JUN—hematologic cancer	3.49e-06	1.95e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	3.49e-06	1.95e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	3.48e-06	1.94e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—hematologic cancer	3.48e-06	1.94e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TP53—hematologic cancer	3.46e-06	1.93e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	3.46e-06	1.93e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	3.45e-06	1.92e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	3.44e-06	1.92e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	3.44e-06	1.92e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PTEN—hematologic cancer	3.43e-06	1.91e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	3.43e-06	1.91e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—PIK3CA—hematologic cancer	3.43e-06	1.91e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	3.43e-06	1.91e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	3.42e-06	1.91e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	3.42e-06	1.91e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	3.42e-06	1.91e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	3.41e-06	1.9e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	3.41e-06	1.9e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	3.4e-06	1.89e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	3.39e-06	1.89e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.39e-06	1.89e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	3.39e-06	1.89e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	3.38e-06	1.89e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	3.38e-06	1.89e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	3.38e-06	1.88e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	3.38e-06	1.88e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	3.37e-06	1.88e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	3.37e-06	1.88e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	3.36e-06	1.87e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	3.36e-06	1.87e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HRAS—hematologic cancer	3.36e-06	1.87e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	3.36e-06	1.87e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	3.35e-06	1.87e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	3.35e-06	1.87e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.34e-06	1.86e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	3.34e-06	1.86e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	3.34e-06	1.86e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EP300—hematologic cancer	3.33e-06	1.86e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	3.33e-06	1.86e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	3.33e-06	1.85e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	3.33e-06	1.85e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.32e-06	1.85e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TP53—hematologic cancer	3.32e-06	1.85e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HRAS—hematologic cancer	3.31e-06	1.85e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	3.31e-06	1.84e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	3.3e-06	1.84e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	3.3e-06	1.84e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	3.3e-06	1.84e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MYC—hematologic cancer	3.29e-06	1.83e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	3.29e-06	1.83e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	3.28e-06	1.83e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EP300—hematologic cancer	3.28e-06	1.83e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EP300—hematologic cancer	3.27e-06	1.82e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.27e-06	1.82e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	3.27e-06	1.82e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EP300—hematologic cancer	3.26e-06	1.82e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EP300—hematologic cancer	3.25e-06	1.81e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.24e-06	1.81e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.24e-06	1.81e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	3.24e-06	1.81e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SRC—hematologic cancer	3.24e-06	1.81e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	3.24e-06	1.81e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	3.24e-06	1.8e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	3.22e-06	1.8e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EP300—hematologic cancer	3.22e-06	1.8e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—hematologic cancer	3.21e-06	1.79e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	3.21e-06	1.79e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.21e-06	1.79e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SRC—hematologic cancer	3.19e-06	1.78e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SRC—hematologic cancer	3.18e-06	1.77e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SRC—hematologic cancer	3.17e-06	1.77e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HRAS—hematologic cancer	3.17e-06	1.77e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—hematologic cancer	3.17e-06	1.77e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—hematologic cancer	3.17e-06	1.77e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SRC—hematologic cancer	3.16e-06	1.76e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TP53—hematologic cancer	3.16e-06	1.76e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	3.16e-06	1.76e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	3.15e-06	1.76e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	3.14e-06	1.75e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	3.14e-06	1.75e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SRC—hematologic cancer	3.13e-06	1.75e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	3.13e-06	1.74e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	3.13e-06	1.74e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	3.12e-06	1.74e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.12e-06	1.74e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	3.12e-06	1.74e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	3.12e-06	1.74e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	3.11e-06	1.73e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	3.1e-06	1.73e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	3.09e-06	1.72e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	3.08e-06	1.72e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	3.08e-06	1.71e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—STAT3—hematologic cancer	3.07e-06	1.71e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	3.07e-06	1.71e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.07e-06	1.71e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—NRAS—hematologic cancer	3.06e-06	1.71e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	3.06e-06	1.71e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	3.06e-06	1.71e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	3.05e-06	1.7e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	3.05e-06	1.7e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	3.05e-06	1.7e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	3.05e-06	1.7e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	3.04e-06	1.7e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	3.04e-06	1.7e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	3.04e-06	1.7e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—hematologic cancer	3.04e-06	1.69e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.03e-06	1.69e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HRAS—hematologic cancer	3.02e-06	1.68e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	3.02e-06	1.68e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	3.01e-06	1.68e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	3.01e-06	1.68e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	3.01e-06	1.67e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	2.99e-06	1.67e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	2.98e-06	1.66e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	2.98e-06	1.66e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AKT1—hematologic cancer	2.96e-06	1.65e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	2.94e-06	1.64e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.93e-06	1.63e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	2.92e-06	1.63e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	2.92e-06	1.63e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	2.91e-06	1.62e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	2.91e-06	1.62e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MYC—hematologic cancer	2.91e-06	1.62e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	2.9e-06	1.62e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	2.9e-06	1.62e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.89e-06	1.61e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—hematologic cancer	2.89e-06	1.61e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	2.89e-06	1.61e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	2.88e-06	1.6e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—PIK3CA—hematologic cancer	2.88e-06	1.6e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.87e-06	1.6e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MYC—hematologic cancer	2.86e-06	1.59e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	2.85e-06	1.59e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MYC—hematologic cancer	2.85e-06	1.59e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	2.85e-06	1.59e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	2.85e-06	1.59e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MYC—hematologic cancer	2.84e-06	1.58e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	2.84e-06	1.58e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MYC—hematologic cancer	2.83e-06	1.58e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	2.83e-06	1.58e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	2.83e-06	1.58e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MYC—hematologic cancer	2.81e-06	1.56e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AKT1—hematologic cancer	2.8e-06	1.56e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	2.8e-06	1.56e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	2.8e-06	1.56e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	2.8e-06	1.56e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.8e-06	1.56e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	2.79e-06	1.56e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	2.79e-06	1.56e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	2.79e-06	1.56e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.74e-06	1.53e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—hematologic cancer	2.71e-06	1.51e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TP53—hematologic cancer	2.7e-06	1.51e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	2.68e-06	1.5e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	2.68e-06	1.49e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	2.67e-06	1.49e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AKT1—hematologic cancer	2.67e-06	1.49e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.65e-06	1.48e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	2.64e-06	1.47e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	2.64e-06	1.47e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—KRAS—hematologic cancer	2.64e-06	1.47e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	2.63e-06	1.47e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	2.63e-06	1.46e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	2.62e-06	1.46e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	2.6e-06	1.45e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	2.59e-06	1.45e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	2.59e-06	1.45e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.59e-06	1.44e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	2.59e-06	1.44e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	2.59e-06	1.44e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	2.59e-06	1.44e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—EP300—hematologic cancer	2.53e-06	1.41e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	2.48e-06	1.38e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—hematologic cancer	2.47e-06	1.38e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	2.47e-06	1.37e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	2.43e-06	1.35e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	2.42e-06	1.35e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTEN—hematologic cancer	2.42e-06	1.35e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.41e-06	1.35e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.41e-06	1.34e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	2.41e-06	1.34e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	2.4e-06	1.34e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.39e-06	1.33e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TP53—hematologic cancer	2.39e-06	1.33e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	2.38e-06	1.33e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	2.38e-06	1.32e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	2.37e-06	1.32e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—AKT1—hematologic cancer	2.35e-06	1.31e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TP53—hematologic cancer	2.35e-06	1.31e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TP53—hematologic cancer	2.34e-06	1.31e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TP53—hematologic cancer	2.34e-06	1.3e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TP53—hematologic cancer	2.33e-06	1.3e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—EP300—hematologic cancer	2.31e-06	1.29e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TP53—hematologic cancer	2.31e-06	1.28e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	2.3e-06	1.28e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	2.28e-06	1.27e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	2.28e-06	1.27e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	2.25e-06	1.25e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HRAS—hematologic cancer	2.24e-06	1.25e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	2.23e-06	1.24e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.23e-06	1.24e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	2.23e-06	1.24e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	2.21e-06	1.23e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	2.2e-06	1.23e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	2.2e-06	1.23e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	2.19e-06	1.22e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—hematologic cancer	2.18e-06	1.22e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—AKT1—hematologic cancer	2.16e-06	1.2e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—hematologic cancer	2.15e-06	1.2e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—hematologic cancer	2.14e-06	1.2e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—hematologic cancer	2.14e-06	1.19e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	2.14e-06	1.19e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—hematologic cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.12e-06	1.18e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—hematologic cancer	2.11e-06	1.18e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	2.1e-06	1.17e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—hematologic cancer	2.09e-06	1.16e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTEN—hematologic cancer	2.07e-06	1.15e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	2.04e-06	1.14e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	2.01e-06	1.12e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2e-06	1.11e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.98e-06	1.11e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.98e-06	1.1e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	1.97e-06	1.1e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—EP300—hematologic cancer	1.97e-06	1.1e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	1.97e-06	1.1e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	1.96e-06	1.09e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.95e-06	1.08e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	1.94e-06	1.08e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.87e-06	1.04e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.85e-06	1.03e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	1.8e-06	1.01e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.71e-06	9.51e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.59e-06	8.89e-06	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.53e-06	8.52e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—EP300—hematologic cancer	1.52e-06	8.48e-06	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.46e-06	8.12e-06	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.39e-06	7.77e-06	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.19e-06	6.64e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.12e-06	6.27e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AKT1—hematologic cancer	9.19e-07	5.12e-06	CbGpPWpGaD
